Outlook on the neuroprotective effect of estrogen.

No Thumbnail Available

Date

2017

Authors

d'Anglemont de Tassigny, Xavier

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Wolters Kluwer - Medknow Publications and Media Pvt. Ltd.
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Epidemiologic studies often consider gender differences in a particular pathology, and constantly observe variations between men and women. Indeed, a remarkable sexual dimorphism exists in the epidemiology of neurological conditions and brain diseases. Physiologically, males and females differ by their levels of circulating hormones that drive sexual behavioral, as well as endocrine functions. Estrogen is the primary female sex hormonal group that enwraps estradiol, estrone and estriol, and which are the major naturally occurring hormones prevalent in women. Their role in the reproductive function has long been established, although the ubiquitous expression of its receptors (alpha, beta and G protein-coupled, GPR30) presumes a broader spectrum of action. This short review will summarize the current knowledge in estrogen therapy with particular focus on some of the recent work that might lead to new neuroprotective treatments.

Description

MeSH Terms

Male
Female
Sex characteristics
Estrone
Sex factors
GTP-Binding proteins

DeCS Terms

Terapéutica
Terapéutica
Hormonas
Caracteres sexuales
Estrógenos
Epidemiología
Encefalopatías
Estrona
Estradiol
Proteínas de unión al GTP
Estriol

CIE Terms

Keywords

Estrogens, Estradiol, Nervous system diseases, Estriol, Brain diseases

Citation

d'Anglemont de Tassigny X. Outlook on the neuroprotective effect of estrogen. Neural Regen Res. 2017 Nov;12(11):1799-1800